Combining vaccination with wMel for dengue control in Brazil
Finch, E.; Huang, A. T.; McCormack, C.; Vicco, A.; Croda, J.; Ferguson, N. M.; Dorigatti, I.; Salje, H.
Show abstract
Dengue virus is a severe threat to global health. Novel vaccine and Wolbachia technologies offer a potential path to dengue control; however, it remains unclear how to use these approaches in tandem. Using metapopulation transmission models, we simulated future dengue burden in Brazil. We estimated that wMel releases in 300 municipalities could avert 12-22% of cases over the next 10 years, while a national vaccination campaign could avert 8-10% of cases in the total population and 39-45% within the vaccinated cohort. Projecting forward 40 years, we found wMel releases would drive up the mean age of cases beyond increases due to the ageing population and increase population susceptibility to dengue. Finally, wMel releases can help mitigate the future burden in southern Brazil where climate change is rapidly increasing dengue virus risk. These findings highlight the need to consider the two technologies in parallel to optimise efforts to combat future dengue burden.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.